loading

Dbv Technologies Adr Aktie (DBVT) Neueste Nachrichten

pulisher
Jul 22, 2025

European ADRs Inch Higher As Drugmakers Shine - Finimize

Jul 22, 2025
pulisher
Jul 22, 2025

DBV Technologies Announces Appointment of James Briggs as Chief Human Resources Officer - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

DBV Technologies Taps Healthcare Veteran as CHRO to Drive Commercial Evolution - Stock Titan

Jul 22, 2025
pulisher
Jul 20, 2025

What analysts say about DBV Technologies S.A. Depositary Receipt stockHigh-impact stock picks - Autocar Professional

Jul 20, 2025
pulisher
Jul 14, 2025

European Stocks In The US Finish With A Modest Rebound - Finimize

Jul 14, 2025
pulisher
Jul 10, 2025

European ADRs Climb As Verona Pharma Leads Gains - Finimize

Jul 10, 2025
pulisher
Jul 08, 2025

European ADRs Climb As Sequans Leads The Charge - Finimize

Jul 08, 2025
pulisher
Jul 07, 2025

DBV Technologies’ SWOT analysis: peanut allergy patch stock poised for growth - Investing.com India

Jul 07, 2025
pulisher
Jul 05, 2025

DBV Technologies (NASDAQ:DBVT) Upgraded to Hold at Wall Street Zen - Defense World

Jul 05, 2025
pulisher
Jul 01, 2025

European Stocks Climb As ADRs Post Gains - Finimize

Jul 01, 2025
pulisher
Jul 01, 2025

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

Jul 01, 2025
pulisher
Jun 30, 2025

Research Analysts Set Expectations for DBVT Q2 Earnings - Defense World

Jun 30, 2025
pulisher
Jun 28, 2025

Lifesci Capital Upgrades DBV Technologies (NASDAQ:DBVT) to Strong-Buy - Defense World

Jun 28, 2025
pulisher
Jun 27, 2025

European Biopharma Leads Gains In ADR Market Surge - Finimize

Jun 27, 2025
pulisher
Jun 27, 2025

European Biotech ADRs Lead the Charge: A Sector on the Verge of Breakthrough Growth - AInvest

Jun 27, 2025
pulisher
Jun 26, 2025

European ADRs Dip As Biotech Stocks Show Mixed Results - Finimize

Jun 26, 2025
pulisher
Jun 26, 2025

DBV Technologies stock holds steady as JMP reiterates $21 price target - Investing.com

Jun 26, 2025
pulisher
Jun 25, 2025

Breakthrough Peanut Allergy Treatment Enters Critical Phase 3 Trial for Toddlers as Young as 12 Months - Stock Titan

Jun 25, 2025
pulisher
Jun 21, 2025

European ADRs Dip As Evaxion And Grifols Climb - Finimize

Jun 21, 2025
pulisher
Jun 18, 2025

European ADRs Dip While Biotech And Energy See Gains - Finimize

Jun 18, 2025
pulisher
Jun 16, 2025

European Stocks Shine As ADRs Climb Higher - Finimize

Jun 16, 2025
pulisher
Jun 14, 2025

DBV Technologies (NASDAQ:DBVT) Stock Price Crosses Above 50 Day Moving Average – Here’s Why - Defense World

Jun 14, 2025
pulisher
Jun 12, 2025

DBV Technologies to Participate in Upcoming EAACI Congress 2025 - The Manila Times

Jun 12, 2025
pulisher
Jun 11, 2025

DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting - GlobeNewswire

Jun 11, 2025
pulisher
Jun 11, 2025

DBV Technologies Secures Full Shareholder Support at Annual Meeting: Key Governance Updates - Stock Titan

Jun 11, 2025
pulisher
Jun 03, 2025

DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document - GlobeNewswire

Jun 03, 2025
pulisher
Jun 03, 2025

DBV Technologies Reveals Special CEO Pay Package Ahead of Critical Shareholder Vote - Stock Titan

Jun 03, 2025
pulisher
Jun 03, 2025

European ADRs Climb With Biotech Stocks Leading The Charge - Finimize

Jun 03, 2025
pulisher
May 31, 2025

European ADRs Show Strength With Genfit And Novo Nordisk Leading Gains - Finimize

May 31, 2025
pulisher
May 30, 2025

DBV Technologies (NASDAQ:DBVT) Raised to Sell at The Goldman Sachs Group - Defense World

May 30, 2025
pulisher
May 29, 2025

Goldman Sachs cuts DBV Technologies stock to Sell, target EUR1.30 By Investing.com - Investing.com South Africa

May 29, 2025
pulisher
May 29, 2025

Goldman Sachs cuts DBV Technologies stock to Sell, target EUR1.30 - Investing.com India

May 29, 2025
pulisher
May 29, 2025

Goldman Sachs reinstates DBV Technologies with sell rating, $7.25 target By Investing.com - Investing.com India

May 29, 2025
pulisher
May 29, 2025

Goldman Sachs reinstates DBV Technologies with sell rating, $7.25 target - Investing.com

May 29, 2025
pulisher
May 28, 2025

DBV Technologies (NASDAQ:DBVT) Price Target Raised to $21.00 at JMP Securities - Defense World

May 28, 2025
pulisher
May 27, 2025

European ADRs Rise On S&P Europe Select Index - Finimize

May 27, 2025
pulisher
May 26, 2025

DBV Technologies’ SWOT analysis: peanut allergy treatment stock faces pivotal trial - Investing.com

May 26, 2025
pulisher
May 22, 2025

European ADRs Show Optimism As Genfit Leads Gains - Finimize

May 22, 2025
pulisher
May 22, 2025

European ADRs Slip As US Index Notes Mixed Gains And Losses - Finimize

May 22, 2025
pulisher
May 18, 2025

Comparing DBV Technologies (NASDAQ:DBVT) and Maze Therapeutics (NASDAQ:MAZE) - Defense World

May 18, 2025
pulisher
May 16, 2025

Are You Looking for a Top Momentum Pick? Why DBV Technologies S.A. (DBVT) is a Great Choice - Nasdaq

May 16, 2025
pulisher
May 16, 2025

European ADRs Dip As Pharma And Tech Stocks See Mixed Results - Finimize

May 16, 2025
pulisher
May 15, 2025

Combined General Meeting of June 11, 2025 - GlobeNewswire

May 15, 2025
$22.89
price up icon 5.02%
$35.95
price down icon 0.40%
$102.86
price down icon 0.07%
$27.68
price up icon 4.45%
$113.60
price up icon 1.92%
biotechnology ONC
$295.35
price down icon 0.08%
Kapitalisierung:     |  Volumen (24h):